Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pollakiuria, Pruritus, Pyrexia, SARS-CoV-2 antibody test, Weight decreased
Clinical narrative: Lightheaded; Weak; Migraines; Sore arm; Extreme fatigue/ exhaustion; Elevated fever; Chills; Skin itching burning; Skin itching burning; Increased urination; Periods started for the 1st time in 2yrs/Developed reoccurance of menstrual cycle; Forgetfullness; Hot flashes; Sinus pressure; Hair loss; Unexplained weight loss; Subdermal bruising; Hypersensitivity; Possibly contracted covid after exposure to covid patient; Increased wheezing; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Skin itching burning), POLLAKIURIA (Increased urination), MENSTRUAL DISORDER (Periods started for the 1st time in 2yrs/Developed reoccurance of menstrual cycle), MEMORY IMPAIRMENT (Forgetfullness) and HOT FLUSH (Hot flashes) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma (Increased wheezing) since 1990, Antiphospholipid syndrome (Antiphospholipid antibody syndrome) since 2012 and Drug allergy (Reactive to other medications, body is complex and behaves weird with medications). Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) from an unknown date to 01-Mar-2021 and TOPIRAMATE from an unknown date to 01-Apr-2021 for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced WHEEZING (Increased wheezing). On 22-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (Possibly contracted covid after exposure to covid patient). On 28-Feb-2021, the patient experienced BURNING SENSATION (Skin itching burning), POLLAKIURIA (Increased urination), MENSTRUAL DISORDER (Periods started for the 1st time in 2yrs/Developed reoccurance of menstrual cycle), MEMORY IMPAIRMENT (Forgetfullness), HOT FLUSH (Hot flashes), PARANASAL SINUS DISCOMFORT (Sinus pressure), ALOPECIA (Hair loss), WEIGHT DECREASED (Unexplained weight loss), CONTUSION (Subdermal bruising), HYPERSENSITIVITY (Hypersensitivity), PRURITUS (Skin itching burning), FATIGUE (Extreme fatigue/ exhaustion), PYREXIA (Elevated fever) and CHILLS (Chills). On an unknown date, the patient experienced DIZZINESS (Lightheaded), ASTHENIA (Weak), MIGRAINE (Migraines) and PAIN IN EXTREMITY (Sore arm). At the time of the report, BURNING SENSATION (Skin itching burning), POLLAKIURIA (Increased urination), MEMORY IMPAIRMENT (Forgetfullness), PARANASAL SINUS DISCOMFORT (Sinus pressure), WEIGHT DECREASED (Unexplained weight loss), CONTUSION (Subdermal bruising), HYPERSENSITIVITY (Hypersensitivity), COVID-19 (Possibly contracted covid after exposure to covid patient), DIZZINESS (Lightheaded), ASTHENIA (Weak), MIGRAINE (Migraines), PRURITUS (Skin itching burning), WHEEZING (Increased wheezing), PAIN IN EXTREMITY (Sore arm), FATIGUE (Extreme fatigue/ exhaustion), PYREXIA (Elevated fever) and CHILLS (Chills) outcome was unknown and MENSTRUAL DISORDER (Periods started for the 1st time in 2yrs/Developed reoccurance of menstrual cycle), HOT FLUSH (Hot flashes) and ALOPECIA (Hair loss) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, SARS-CoV-2 antibody test: unknown (Positive) SARS-CoV-2 Antibody IGG positive.         It was reported that patient had been to her PCP, rheumatologist, gynecologist and immunologist and several tests and ultrasounds and biopsies was done No treatment medication was reported   This case was linked to US-MODERNATX, INC.-MOD-2021-077953 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow up received on 18-May-2021 contains significant information added medical history, concomitant medications, new events and the outcome of the event alopecia, menstrual disorder and hot flush changed from unknown to not resolved .Updated reporter details.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077953:cross linked to dose 1